Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
BioAtla, Inc. Income Statement Banner

BioAtla, Inc. Income Statement

BCAB Stock Analysis

Page title

Section title

Breakdown
2018
2019
2020
2021
2022
2023
Total Revenue
10.627M5.200M429.000K250.000K0.0000.000
Cost of Revenue
26.305M25.919K19.933K1.330M1.199M103.731M
Gross Profit
-15.678m5.174M409.067K-1.080m-1.199m-103.731m
Operating Expense
38.861M33.468M30.528M96.690M108.140M26.043M
Operating Income
-28.234m-28.268m-30.099m-96.440m-108.140m-129.687m
Other Income Expense
-5.000k-22.000k-1.000k1.000K10.000K0.000
Total Other Income Expense
-5.000k-1.587m-5.754m1.038M1.658M6.225M
Pretax Income
-28.979m-29.855m-35.853m-95.402m-106.482m-123.462m
Tax Provision
204.000K1.547M1.388M4.000K-1.199m0.000
Net Income
-28.979m-31.402m-37.241m-95.406m-105.283m-123.462m
Basic EPS
-1.340-0.930-1.110-2.760-2.700-2.580
Diluted EPS
-1.340-0.930-1.110-2.760-2.700-2.580
Basic Average Shares
21.589M33.664M33.664M34.561M38.927M47.777M
Diluted Average Shares
21.589M33.664M33.664M34.561M38.927M47.778M
Total Expenses
38.861M33.468M30.528M96.690M108.140M129.774M
Interest Income
209.000K128.000K100.000K350.000K1.648M6.312M
Interest Expense
949.000K1.630M1.389M3.000K-1.658m0.000
EBITDA
-27.236m-27.302m-28.992m-94.759m-106.482m-128.466m
Depreciation & Amortization
794.000K860.000K1.008M1.330M1.199M1.221M